Skye Bioscience
Eduardo Muñoz is a scientific advisor at Skye Bioscience. Eduardo has previously worked as a co-founder at innoHealth Group (EVONIK), founder at VivaCell Biotechnology España, and at Universidad de Córdoba.
Eduardo Muñoz attended medical school at the Universidad de Córdoba, where they earned their degree in medicine and surgery.
This person is not in the org chart
This person is not in any offices
Skye Bioscience
Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.